More Dismal performance.TA. First sales of TA expected to...

More Dismal performance.

TA. First sales of TA expected to commence Q1 2008, its nearly the end of Q2? Have there been any sales by Alcon at all? they may not have paid royalties but this sounds like AOS dont even know if TA is even being sold yet. If it is then how much does it sell for? If you know how much a dose of Avastin costs then tell us how much a dose of TA costs? Now they say the markets diminished cause Avastin is only $40. If Ta is that cheap then a few percent royalty will give us bugger all royalty.

Tetraflex. Look at last years AGM pres. they say FDA approval in Q1 09. This year no comment so presumably it will be delayed even later. Forecast income $250-300k you have to be kidding last year they said potential income +$2m p.a. $250k is barely enough to cover directors fees.

Omnifocal. Last years preso. there was a whole project plan for this, Q407 prototype construction, Clinical Trials to start in Q3 08 CE Mark approval Q1 09 and sales in Europe in Q2 09. Now we are doing a scoping study with results in Q3 08 when last year we were told this great product would be in clinical trials in Q3 08. AOS bought this thing in 2006 if it has potential why has it taken two years before a basic scoping study is completed ? This is already two years behind schedule and will probably miss the market like Tetraflex because the big guys move much faster with their products. omnifoical could take years to get approved and wheres the money going to come from to develop it? oh yeh probably from the profits from the vacant land we got a second mortgage on somewhere on the outskirts of perth. That land still hasn't got DA approval yet we have already handed over $1.8m before DA approval. Also it sounds liker theres a glut of cheap housing blocks already so hopefully we'll get our money back.

CLk-pai-lasik. Last year they said they were looking to sell it, this year they didnt mention in the preso that it got sold off for 10% of what AOS bought it for three years ago. another winner.

Cash. $2.1m This is the only thing of any value and with 521.5m shares thats only 0.4c per share so at 1.0c AOS shares look expensive. I can kiss my 5c oppie goodbye. The sale to oculus failed, pilasik got flogged for a fraction of its cost, evrything else is running really late in getting to market and now getting hammered by competitors.

In fact TA was licensed to alcon in 2005, they bought the tetraflex lens in 2005 that was already licensed to lenstec so AOS hasn't achieved a single thing in three years other than blow TENS OF MILLIONS of bucks. everything they said they'd do has FAILED completely.